What’s more, growing studies have reported that the immune-related features of cancers such as the intensity of CD4+ T cells and CD8+ T cell infiltrates, macrophages, and natural killer (NK) cells, different B cell sub-populations were correlated with immunotherapeutic responsiveness in lung cancer (Stankovic et al., 2018). Here, CD8A is linked to lung carcinoma.